title: Prevention of processes coupled with free radical formation prevents also the development of calcium-resistance in the diabetic heart.
abstract: Recently it was shown that besides their negative role in pathogenesis of diabetes, reactive oxygen species (ROS) and particularly the products of non-enzymatic glycation of proteins (NEGP) may also participate in some processes of adaptation of the myocardium to diabetes, such as in the mechanism of development of calcium resistance of the heart. Our study revealed that the hearts of rats with experimentally induced diabetes (single dose of streptozotocin, 45 mg/kg i.v., 6 U/kg insulin daily) develop considerable resistance against calcium overload (induced by means of Ca-paradox). On the day 63 after the beginning of experiment, when the diabetic cardiomyopathy became fully developed but the hearts were still not failing, their calcium resistance was increased to 83.33%. Our results provide evidence that, when applied in a special regimen, resorcylidene aminoguanidine (RAG, 4 mg/kg) prevented both, the formation of fructosamine (a source of ROS generation), and also that of the advanced Maillard products, in the heart sarcolemma of diabetic rats. The effect of RAG was accompanied by a decrease in calcium resistance in the group of rats with chronic diabetes (63 days) from 83.3 to 46.7%. It is concluded that NEGP and ROS formation are inevitably needed for development of calcium resistance in the diabetic hearts.
authors.affiliation: Institute for Heart Research, Slovak Academy of Sciences, Bratislava, Slovak Republic.
authors.forename: A
authors.initials: A
authors.lastname: Ziegelhöffer
authors.forename: J
authors.initials: J
authors.lastname: Styk
authors.forename: T
authors.initials: T
authors.lastname: Ravingerová
authors.forename: J
authors.initials: J
authors.lastname: Seboková
authors.forename: K
authors.initials: K
authors.lastname: Volkovová
authors.forename: I
authors.initials: I
authors.lastname: Waczulíková
authors.forename: J
authors.initials: J
authors.lastname: Cársky
authors.forename: A
authors.initials: A
authors.lastname: Dzurba
authors.forename: P
authors.initials: P
authors.lastname: Docolomanský
mesh_terms: D000818:Animals; D000975:Antioxidants / Q000494:pharmacology*; D002118:Calcium / Q000378:metabolism*; D003921:Diabetes Mellitus, Experimental / Q000378:metabolism*; D005609:Free Radicals / Q000378:metabolism; D006023:Glycoproteins / Q000378:metabolism; D006146:Guanidines / Q000494:pharmacology; D008297:Male; D009206:Myocardium / Q000378:metabolism*; D051381:Rats; D017208:Rats, Wistar; D017382:Reactive Oxygen Species / Q000378:metabolism; D012508:Sarcolemma / Q000187:drug effects / Q000378:metabolism
chemical_list: D000975:Antioxidants; D005609:Free Radicals; D006023:Glycoproteins; D006146:Guanidines; D017382:Reactive Oxygen Species; C115168:resorcylidene aminoguanidine; D002118:Calcium